Latest research has shown that c-ABL can enhance the anti-tumor action of ERβ by directly controlling the status of phosphotyrosine residue (Y36).17 Therefore, regulation of c-ABL/ERβ signal maybe one potent therapeutic method for PCa. The gene discussed is ESR2; the disease is posterior cortical atrophy.